Neonatal Abstinence Syndrome (NAS) secondary to in-utero exposure has increased 5-fold in the US. Providing clinical recommendations, developing safe guidelines to improve care for women with opioid use disorders and their neonates is gaining in priority for programming, policy and research. The panel will discuss NAS through the lens of neonatal and long-term development. Public health and research perspectives will be condensed, with the aim to translate data into a practical clinical guide. The panel will explore compassionate ways to normalize postpartum care while supporting the mom/baby/family triad and the community.

Learning Objectives

1. Upon completion, participants will be able to identify current national data, trends and significant gaps in access to care for neonates and children impacted by NAS.
2. Upon completion, participants will be able to identify practical considerations and benefits of OAT for pregnant/parenting women, and how MAT stability supports mom-baby dyad, engagement, parenting and good NAS outcomes.
3. Upon completion, participants will be able to summarize how the ASAM and ACOG recommendations for NAS translate into a provider practical clinical guide